103 related articles for article (PubMed ID: 11864276)
21. Colonization with slime-positive coagulase-negative staphylococci as a risk factor for invasive coagulase-negative staphylococci infections in neonates.
Hall SL; Hall RT; Barnes WG; Riddell S
J Perinatol; 1988; 8(3):215-21. PubMed ID: 3225663
[TBL] [Abstract][Full Text] [Related]
22. Clinical implications of icaA and icaD genes in coagulase negative staphylococci and Staphylococcus aureus bacteremia in febrile neutropenic pediatric cancer patients.
El-Mahallawy HA; Loutfy SA; El-Wakil M; El-Al AK; Morcos H
Pediatr Blood Cancer; 2009 Jul; 52(7):824-8. PubMed ID: 19214976
[TBL] [Abstract][Full Text] [Related]
23. [Correlation of slime production and pathogenicity of coagulase-negative staphylococci].
Végh Z; Gacs M
Orv Hetil; 1990 Feb; 131(5):231-4. PubMed ID: 2406682
[TBL] [Abstract][Full Text] [Related]
24. In vitro activity of fleroxacin and 14 other antimicrobials against slime- and non-slime-producing Staphylococcus epidermidis.
Kropec A; Daschner F
Chemotherapy; 1989; 35(5):351-4. PubMed ID: 2507234
[TBL] [Abstract][Full Text] [Related]
25. [Phenotypic evaluation of hydrophobicity and the ability to produce biofilm in coagulase-negative staphylococci isolated from infected very-low-birthweight newborns].
Grzebyk M; Brzychczy- WM; Piotrowska A; Krzyściak P; Heczko PB; Bulanda M
Med Dosw Mikrobiol; 2013; 65(3):149-59. PubMed ID: 24432554
[TBL] [Abstract][Full Text] [Related]
26. Ultrastructural analysis of slime positive & slime negative Staphylococcus epidermidis isolates in infectious keratitis.
Nayak N; Nag TC; Satpathy G; Ray SB
Indian J Med Res; 2007 Jun; 125(6):767-71. PubMed ID: 17704554
[TBL] [Abstract][Full Text] [Related]
27. [Antimicrobial sensivity and ability to slime production of koagulaze-negative staphylococci].
Szczuka E; Prawda-Zołotar J; Nowakiewicz M; Kaznowski A
Med Dosw Mikrobiol; 2011; 63(1):15-9. PubMed ID: 22184892
[TBL] [Abstract][Full Text] [Related]
28. A chemically defined medium for slime production by coagulase-negative staphylococci.
Hussain M; Hastings JG; White PJ
J Med Microbiol; 1991 Mar; 34(3):143-7. PubMed ID: 2010904
[TBL] [Abstract][Full Text] [Related]
29. [Risk of coagulase-negative staphylococci infections in catheterized patients due to adhesion and slime production].
Bartoszewicz M; Nowicka J; Przondo-Mordarska A
Pol Merkur Lekarski; 2004 Oct; 17(100):335-7. PubMed ID: 15690695
[TBL] [Abstract][Full Text] [Related]
30. In vitro activity of sulbactam plus ampicillin against hospital isolates of coagulase-negative staphylococci and Acinetobacter species.
Frank U; Daschner FD
Infection; 1989; 17(4):272-4. PubMed ID: 2767773
[TBL] [Abstract][Full Text] [Related]
31. Lack of correlation of slime production with pathogenicity in continuous ambulatory peritoneal dialysis peritonitis caused by coagulase negative staphylococci.
Alexander W; Rimland D
Diagn Microbiol Infect Dis; 1987 Dec; 8(4):215-20. PubMed ID: 3449316
[TBL] [Abstract][Full Text] [Related]
32. Slime production by coagulase-negative staphylococci in the infected pulps.
Alacam T; Alacam A; Sultan N; Bala O; Gungor A; Ozkan S
J Clin Pediatr Dent; 1995; 19(2):117-9. PubMed ID: 7577729
[TBL] [Abstract][Full Text] [Related]
33. Relevance of biofilm formation and virulence of different species of coagulase-negative staphylococci to public health.
Osman KM; Abd El-Razik KA; Marie HS; Arafa A
Eur J Clin Microbiol Infect Dis; 2015 Oct; 34(10):2009-16. PubMed ID: 26173695
[TBL] [Abstract][Full Text] [Related]
34. Usefulness of a test for slime production as a marker for clinically significant infections with coagulase-negative staphylococci.
Davenport DS; Massanari RM; Pfaller MA; Bale MJ; Streed SA; Hierholzer WJ
J Infect Dis; 1986 Feb; 153(2):332-9. PubMed ID: 2935582
[TBL] [Abstract][Full Text] [Related]
35. Slime production and cell surface hydrophobicity of nasopharyngeal and skin staphylococci isolated from healthy people.
Malm A; Biernasiuk A; Loś R; Kosikowska U; Juda M; Korona-Głowniak I; Górniewski G
Pol J Microbiol; 2005; 54(2):117-21. PubMed ID: 16209105
[TBL] [Abstract][Full Text] [Related]
36. [Ability of slime production Staphylococcus aureus strains obtained from clinical materials].
Szymankiewicz M; Janicka G; Wróblewska J
Pol Merkur Lekarski; 2004 Oct; 17(100):338-40. PubMed ID: 15690696
[TBL] [Abstract][Full Text] [Related]
37. [Evaluation of 2 methods for studying slime production by coagulase-negative Staphylococcus strains].
Sánchez G; Pascual A; Martínez-Martínez L
Enferm Infecc Microbiol Clin; 1989 May; 7(5):252-6. PubMed ID: 2490721
[TBL] [Abstract][Full Text] [Related]
38. Activity of vancomycin, ciprofloxacin, daptomycin, and linezolid against coagulase-negative staphylococci bacteremia.
Fajardo Olivares M; Hidalgo Orozco R; Rodríguez Garrido S; Rodríguez-Vidigal FF; Vera Tomé A; Robles Marcos M
Rev Esp Quimioter; 2011 Jun; 24(2):74-8. PubMed ID: 21666998
[TBL] [Abstract][Full Text] [Related]
39. [The rate of inducible clindamycin resistance and susceptibilities to other antimicrobial agents in staphylococci].
Oğuz VA; Yapar N; Sezak N; Cavuş SA; Kurutepe S; Peksel H; Cakir N; Yüce A
Mikrobiyol Bul; 2009 Jan; 43(1):37-44. PubMed ID: 19334378
[TBL] [Abstract][Full Text] [Related]
40. Slime producing Staphylococci from clinical specimens - a simple diagnostic test.
Makhija SK; Jalgaonkar SV; Kher MM
Indian J Pathol Microbiol; 1995 Apr; 38(2):159-61. PubMed ID: 8919101
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
